Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Guanosine is a purine nucleoside, in which the guanine is attached to the C1 carbon of a ribose (ribofuranose) ring via a β-N9-glycosidic bond. It is an aromatic organic molecule and a constituent of nucleic acids, playing a crucial role in various biochemical processes such as synthesis of nucleic acids and proteins, photosynthesis, muscle contraction, and intracellular signal transduction. Guanosine is also thought to have neuroprotective properties, being protective in central nervous system diseases and is associated with purine nucleoside phosphorylase (PNP) deficiency.

118-00-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 118-00-3 Structure
  • Basic information

    1. Product Name: Guanosine
    2. Synonyms: usafcb-11;O-(BETA-D-RIBOFURANOSYL)GUANINE;D-GUANOSINE;GR;GUANOSINE;GUANINE-9-BETA-D-RIBOFURANOSIDE;GUANINE RIBOSIDE;9-[BETA-D-RIBOFURANOSYL]GUANINE
    3. CAS NO:118-00-3
    4. Molecular Formula: C10H13N5O5
    5. Molecular Weight: 283.24
    6. EINECS: 204-227-8
    7. Product Categories: Pharmaceutical Intermediates;Purine;API intermediates;Nucleotides and Nucleosides;Biochemistry;Nucleosides and their analogs;Nucleosides, Nucleotides & Related Reagents;Nucleic acids;Bases & Related Reagents;Nucleotides;Carbohydrates & Derivatives;nucleoside;Inhibitors
    8. Mol File: 118-00-3.mol
  • Chemical Properties

    1. Melting Point: 250 °C (dec.)(lit.)
    2. Boiling Point: 425.8°C (rough estimate)
    3. Flash Point: 423.1oC
    4. Appearance: White to light yellow/Powder
    5. Density: 1.3790 (rough estimate)
    6. Vapor Pressure: 2.44E-25mmHg at 25°C
    7. Refractive Index: -76 ° (C=1, 1mol/L NaOH)
    8. Storage Temp.: Store at RT.
    9. Solubility: 0.1 M NaOH: 0.1 g/mL, clear, slightly yellow
    10. PKA: pK1:1.9(+1);pK2:9.25(0);pK3:12.33(OH) (25°C)
    11. Water Solubility: 0.75 g/L (25 ºC)
    12. Merck: 14,4566
    13. BRN: 625911
    14. CAS DataBase Reference: Guanosine(CAS DataBase Reference)
    15. NIST Chemistry Reference: Guanosine(118-00-3)
    16. EPA Substance Registry System: Guanosine(118-00-3)
  • Safety Data

    1. Hazard Codes: T,Xi
    2. Statements: 25
    3. Safety Statements: 45-24/25-23
    4. RIDADR: UN 2811 6.1/PG 3
    5. WGK Germany: 3
    6. RTECS: MF8750000
    7. F: 10-23
    8. TSCA: Yes
    9. HazardClass: 6.1
    10. PackingGroup:
    11. Hazardous Substances Data: 118-00-3(Hazardous Substances Data)

118-00-3 Usage

Uses

Used in Analytical Chemistry:
Guanosine is used as a reference standard for the analysis of glucosinolates by high-performance liquid chromatography with diode-array detection and electrospray ionization tandem mass spectrometry (HPLC-DAD-ESI/MS).
Used in Cell Culture Applications:
Guanosine is used as a component of Mouse Embryonic Fibroblasts (MEFs) culture and as a standard for the detection of residual RNA contaminant in oil palm plant genome samples by HPLC. It is also used in cell culture applications as a precursor of GMP.
Used in Various Industries:
Guanosine is used in metallic paints, simulated pearls, plastics, and the cosmetics industry. It has also been used in pharmacokinetics as a prodrug.
Chemical Properties:
Guanosine is a white, crystalline powder that is odorless and has a mild saline taste. It is very slightly soluble in cold water, soluble in boiling water, dilute mineral acids, hot acetic acid, and dilute bases, and insoluble in alcohol, ether, chloroform, and benzene.

Reference

L. E. B. Bettio, J. Gil-Mohapel, A. L. S. Rodrigues, Guanosine and its role in neurophathologies, Purinergic Signal, 2016, vol. 12, pp. 411-426

Biochem/physiol Actions

Guanosine nucleoside elicits cellular effect as the guanine-based purinergic system. It modulates glutamate uptake by glutamate transporters. It may have neuroprotective functionality in central nervous system disorders. Guanosine promotes neurite arborization, outgrowth, proliferation and differentiation. Administration of guanosine replenished GTP and elicits protective function in renal ischemic injury.

Purification Methods

It crystallises from water as a dihydrate. Dry it at 110o.[Beilstein 26/18 V 81.]

Check Digit Verification of cas no

The CAS Registry Mumber 118-00-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 118-00:
(5*1)+(4*1)+(3*8)+(2*0)+(1*0)=33
33 % 10 = 3
So 118-00-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5+,6-,9+/m1/s1

118-00-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (G0171)  Guanosine  >98.0%(HPLC)(T)

  • 118-00-3

  • 5g

  • 185.00CNY

  • Detail
  • TCI America

  • (G0171)  Guanosine  >98.0%(HPLC)(T)

  • 118-00-3

  • 25g

  • 445.00CNY

  • Detail
  • TCI America

  • (G0171)  Guanosine  >98.0%(HPLC)(T)

  • 118-00-3

  • 100g

  • 1,180.00CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 25g

  • 241.0CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 50g

  • 434.0CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 100g

  • 762.0CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 250g

  • 1763.0CNY

  • Detail

118-00-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name guanosine

1.2 Other means of identification

Product number -
Other names Guanosin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:118-00-3 SDS

118-00-3Synthetic route

2-N-(N,N-dibenzylformamidino)-9-(2,3-O-benzylidene-β-D-ribofuranosyl)-guanine

2-N-(N,N-dibenzylformamidino)-9-(2,3-O-benzylidene-β-D-ribofuranosyl)-guanine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal; palladium hydroxide - carbon In water; tert-butyl alcohol at 20℃; under 2068.59 Torr; for 20h; Hydrogenolysis;99%
2',3'-O-benzylidene-2N-dimethylaminomethylene guanosine

2',3'-O-benzylidene-2N-dimethylaminomethylene guanosine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal; palladium hydroxide - carbon In water; tert-butyl alcohol at 20℃; under 2068.59 Torr; for 20h; Hydrogenolysis;98%
N-2-(ethoxycarbonyl)guanosine
100313-43-7

N-2-(ethoxycarbonyl)guanosine

Conditions
ConditionsYield
With pyridine; ammonium hydroxide at 45℃; for 48h;95%
9-(2',3'-di-O-acetyl-β-D-ribofuranosyl)-N2-isobutanoylguanine

9-(2',3'-di-O-acetyl-β-D-ribofuranosyl)-N2-isobutanoylguanine

Conditions
ConditionsYield
With ammonia In methanol at 25 - 28℃; for 10h;90%
2',3',5'-tri-O-acetyl-guanosine
6979-94-8

2',3',5'-tri-O-acetyl-guanosine

Conditions
ConditionsYield
With methanol; water; triethylamine at 71℃; Microwave irradiation;89%
2-bromo-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)hypoxanthine
41623-91-0

2-bromo-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)hypoxanthine

Conditions
ConditionsYield
With ammonia In methanol at 120℃;80%
With ammonium hydroxide at 150℃; for 3h;48%
Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(6-diphenylcarbamoyloxy-2-isobutyrylamino-purin-9-yl)-tetrahydro-furan-3-yl ester

Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(6-diphenylcarbamoyloxy-2-isobutyrylamino-purin-9-yl)-tetrahydro-furan-3-yl ester

Conditions
ConditionsYield
With methanol; ammonia for 24h; Ambient temperature;80%
2-(acetylamino)-6-(diphenylcarbamoyloxy)-9-(β-D-tri-O-acetylribofuranosyl)-9H-purine
112233-75-7

2-(acetylamino)-6-(diphenylcarbamoyloxy)-9-(β-D-tri-O-acetylribofuranosyl)-9H-purine

Conditions
ConditionsYield
With ammonia In methanol; water at 60℃;75%
With methanol; ammonia for 24h; Ambient temperature;75%
2',1''-anhydro-5-<(1''-benzamido-1''-hydroxymethylene)amino>-1-(β-D-ribofuranosyl)imidazole-4-carboxamide
58917-66-1

2',1''-anhydro-5-<(1''-benzamido-1''-hydroxymethylene)amino>-1-(β-D-ribofuranosyl)imidazole-4-carboxamide

B

[1-(15)N]guanosine

[1-(15)N]guanosine

C

<15NH2>guanosine
103654-70-2

<15NH2>guanosine

Conditions
ConditionsYield
With (15N)-ammonium chloride In dimethyl sulfoxide at 100℃; for 240h; Yields of byproduct given;A n/a
B 75%
C n/a
With (15N)-ammonium chloride In dimethyl sulfoxide at 100℃; for 240h; Yield given. Yields of byproduct given;
8-mercaptoguanosine
26001-38-7

8-mercaptoguanosine

Conditions
ConditionsYield
With potassium bromide In water at 20℃; pH=7; Reagent/catalyst; Inert atmosphere; Irradiation;57.4%
Multi-step reaction with 3 steps
1: dihydrogen peroxide; acetic acid / 48 h / 65 °C
2: lithium hydroxide; water-d2 / Sonication
3: 24 h / 50 °C
View Scheme
1-(β-D-ribofuranosyl)-5-(thiocarbamoyl)amino-1H-imidazole-4-carboxamide
133068-54-9

1-(β-D-ribofuranosyl)-5-(thiocarbamoyl)amino-1H-imidazole-4-carboxamide

Conditions
ConditionsYield
With sodium hydroxide; copper diacetate for 1.5h; Heating;53%
2-Chloroadenosine
146-77-0

2-Chloroadenosine

Conditions
ConditionsYield
With acetic acid; sodium nitrite anschl. Erhitzen mit aethanol. NH3;
α-D-ribofuranosyl-1-phosphate
18646-11-2

α-D-ribofuranosyl-1-phosphate

guanine
73-40-5

guanine

Conditions
ConditionsYield
bei der Einwirkung von Purinnucleosid-Phosphorylase;
Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(2-acetylamino-6-oxo-1,6-dihydro-purin-9-yl)-tetrahydro-furan-3-yl ester
30747-23-0

Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(2-acetylamino-6-oxo-1,6-dihydro-purin-9-yl)-tetrahydro-furan-3-yl ester

Conditions
ConditionsYield
With ammonia In methanol for 42h; Ambient temperature;
Multi-step reaction with 2 steps
1: 77 percent / EtN(i-Pr)2 / pyridine / 1 h / Ambient temperature
2: 75 percent / NH3/MeOH / 24 h / Ambient temperature
View Scheme
N2-acetyl-9-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)guanine
17494-84-7

N2-acetyl-9-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)guanine

Conditions
ConditionsYield
With ammonia In methanol for 42h; Ambient temperature;
2-amino-6-benzyloxy-9-β-D-ribofuranosylpurine
4552-61-8

2-amino-6-benzyloxy-9-β-D-ribofuranosylpurine

A

7-benzylguanosine
72360-76-0

7-benzylguanosine

B

8-benzylguanosine
88158-12-7

8-benzylguanosine

C

N2-benzyl-2'-deoxyguanosine
71171-58-9

N2-benzyl-2'-deoxyguanosine

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;A 0.4 % Chromat.
B 0.5 % Chromat.
C 1.2 % Chromat.
D 97.9 % Chromat.
O6-(p-methylbenzyl)guanosine
79384-30-8

O6-(p-methylbenzyl)guanosine

A

1-(p-methylbenzyl)guanosine
88158-18-3

1-(p-methylbenzyl)guanosine

B

N2-(p-methylbenzyl)guanosine
79396-24-0

N2-(p-methylbenzyl)guanosine

C

8-(p-methylbenzyl)guanosine
88158-13-8

8-(p-methylbenzyl)guanosine

D

C18H21N5O5
104375-85-1

C18H21N5O5

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;A 1.2 % Chromat.
B 3.9 % Chromat.
C 2.6 % Chromat.
D 2.9 % Chromat.
E 89.4 % Chromat.
O6-(p-chlorobenzyl)guanosine
88158-11-6

O6-(p-chlorobenzyl)guanosine

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; for 336h; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;100 % Chromat.
O6-(p-methoxybenzyl)guanosine
78907-22-9

O6-(p-methoxybenzyl)guanosine

A

N2-(p-methoxybenzyl)guanosine
78907-25-2

N2-(p-methoxybenzyl)guanosine

B

1-(p-methoxybenzyl)guanosine
78907-27-4

1-(p-methoxybenzyl)guanosine

C

8-(p-methoxybenzyl)guanosine
78907-24-1

8-(p-methoxybenzyl)guanosine

D

7-(p-methoxybenzyl)guanosine
78907-23-0

7-(p-methoxybenzyl)guanosine

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;A 21.5 % Chromat.
B 0.2 % Chromat.
C 0.4 % Chromat.
D 1.1 % Chromat.
E 76.8 % Chromat.
O6-(p-methoxybenzyl)guanosine
78907-22-9

O6-(p-methoxybenzyl)guanosine

A

N2-(p-methoxybenzyl)guanosine
78907-25-2

N2-(p-methoxybenzyl)guanosine

B

1-(p-methoxybenzyl)guanosine
78907-27-4

1-(p-methoxybenzyl)guanosine

C

8-(p-methoxybenzyl)guanosine
78907-24-1

8-(p-methoxybenzyl)guanosine

D

7-(p-methoxybenzyl)guanosine
78907-23-0

7-(p-methoxybenzyl)guanosine

E

4-(p-methoxybenzyl)-5-guanidino-1-β-D-ribofuranozylimidazole
78907-26-3

4-(p-methoxybenzyl)-5-guanidino-1-β-D-ribofuranozylimidazole

Conditions
ConditionsYield
In methanol; water at 40℃; Rate constant; approximate rate constants for formation of products;

A

cytidine 3'-monophosphate
84-52-6

cytidine 3'-monophosphate

Conditions
ConditionsYield
With ribonuclease A Product distribution; determination of structure;
2'-O-(4-methoxytetrahydropyran-4-yl)guanosine
69471-61-0

2'-O-(4-methoxytetrahydropyran-4-yl)guanosine

Conditions
ConditionsYield
With hydrogenchloride at 22℃; for 0.583333h; Kinetics;50 % Chromat.
3-(β-D-pentofuranosyl)pyrimido<1,2-a>purin-10(3H)-one
78880-62-3

3-(β-D-pentofuranosyl)pyrimido<1,2-a>purin-10(3H)-one

A

Malondialdehyde
542-78-9

Malondialdehyde

Conditions
ConditionsYield
With sodium hydroxide; water at 45℃;
8-amino-3,10-dihydro-10-oxo-3-β-D-ribofuranosyl-1,3,5-triazino<1,2-a>purine
92220-57-0

8-amino-3,10-dihydro-10-oxo-3-β-D-ribofuranosyl-1,3,5-triazino<1,2-a>purine

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 0.0833333h; Product distribution;
N2-<<9-fluorenylmethyl)oxy>carbonyl>guanosine
87424-18-8

N2-<<9-fluorenylmethyl)oxy>carbonyl>guanosine

Conditions
ConditionsYield
With ammonium hydroxide In pyridine at 20℃; for 0.5h;
cytidine guanosine base pair

cytidine guanosine base pair

B

CYTIDINE
65-46-3

CYTIDINE

Conditions
ConditionsYield
In methanol; dimethyl sulfoxide at -26.1 - 29.9℃; Equilibrium constant;
CpCpGp

CpCpGp

A

cytidine 3'-monophosphate
84-52-6

cytidine 3'-monophosphate

Conditions
ConditionsYield
With ribonuclease A Product distribution; determination of structure;
5'-guanosine monophosphate
85-32-5

5'-guanosine monophosphate

Conditions
ConditionsYield
With water at 30℃; for 0.166667h; Rate constant; relative rate, different alkaline phosphotases;
In water at 37℃; for 240h;
guanosine 2',3'-cyclic monophosphate
634-02-6

guanosine 2',3'-cyclic monophosphate

A

guanosine 3'-monophosphate
117-68-0

guanosine 3'-monophosphate

B

guanosine 2'-monophosphate
130-50-7

guanosine 2'-monophosphate

Conditions
ConditionsYield
With chicken plasma membrane protein In water at 30℃; for 2h; Product distribution; other temperatures;
C47H60N18O33P4
99519-21-8

C47H60N18O33P4

B

uridine
58-96-8

uridine

C

CYTIDINE
65-46-3

CYTIDINE

D

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With Croatalus Adamanteus snake venom phosphodiesterase; MgCl2,tris-hydrochloride buffer; monoesterase In water at 37℃; for 18h; Product distribution;
N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

N2-(dimethylaminomethylene)guanosine
17331-16-7

N2-(dimethylaminomethylene)guanosine

Conditions
ConditionsYield
In methanol Ambient temperature;100%
In methanol at 20℃; for 72h;99%
In methanol for 72h;99%
8-bromoguanosine
4016-63-1

8-bromoguanosine

Conditions
ConditionsYield
With bromine In water at 20℃;100%
With bromine In water at 20℃; for 24h;99%
With bromine In water93%
C12H13N7
406945-71-9

C12H13N7

1-(2-amino-9H-purin-6-yl)-4-dimethylamino-pyridinium; 2-amino-9-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-olate

1-(2-amino-9H-purin-6-yl)-4-dimethylamino-pyridinium; 2-amino-9-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-olate

Conditions
ConditionsYield
In water-d2100%
allyl bromide
106-95-6

allyl bromide

7-allyl-2-amino-1H-purine-6(7H)-one
21869-84-1

7-allyl-2-amino-1H-purine-6(7H)-one

Conditions
ConditionsYield
Stage #1: allyl bromide; G In dimethyl sulfoxide at 20℃; for 18h;
Stage #2: With hydrogenchloride; water In dimethyl sulfoxide for 0.75h;
Stage #3: With sodium hydroxide In methanol; water; dimethyl sulfoxide
100%
Stage #1: allyl bromide; G In dimethyl sulfoxide at 20℃; for 18h; Inert atmosphere;
Stage #2: With hydrogenchloride In water; dimethyl sulfoxide for 1h;
92.5%
In dimethyl sulfoxide at 20℃; for 24h; Concentration; Inert atmosphere; Large scale;58.7%
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

acetone
67-64-1

acetone

2',3'-isopropylideneguanosine
362-76-5

2',3'-isopropylideneguanosine

Conditions
ConditionsYield
With toluene-4-sulfonic acid at 20℃; for 72h; Inert atmosphere;100%
acetic anhydride
108-24-7

acetic anhydride

2',3',5'-tri-O-acetyl-guanosine
6979-94-8

2',3',5'-tri-O-acetyl-guanosine

Conditions
ConditionsYield
With dmap; triethylamine In acetonitrile at 0 - 20℃; for 4h;99%
With dmap; triethylamine In acetonitrile for 0.5h; Ambient temperature;98%
With dmap; triethylamine In acetonitrile Heating;98%
<8-2H>guanosine
96412-41-8

<8-2H>guanosine

Conditions
ConditionsYield
With hydrogen; water-d2; palladium on activated charcoal at 110℃; for 24h;99%
With water-d2 for 15h; Heating;92%
With water-d2; palladium on activated charcoal; hydrogen at 110℃; for 24h;92%
chloro(2,2':6',2''-terpyridine)platinum(II) chloride dihydrate

chloro(2,2':6',2''-terpyridine)platinum(II) chloride dihydrate

N(1),N(6)-bis[(2,2':6',2''-terpyridine)platinio(II)]guanosine

N(1),N(6)-bis[(2,2':6',2''-terpyridine)platinio(II)]guanosine

Conditions
ConditionsYield
With silver nitrate In water byproducts: AgCl; Pt-complex and Ag-salt soln. heating at 70-80°C for 2 h, AgCl centrifugation off, org. compd. soln. addn., soln. heating at 70°C for 2 h, centrifugation; soln. freeze drying;99%
2-Methylpropionic anhydride
97-72-3

2-Methylpropionic anhydride

N2-(2-methylpropanoyl)-2',3',5'-tris-O-(2-methylpropanoyl)guanosine
70337-80-3

N2-(2-methylpropanoyl)-2',3',5'-tris-O-(2-methylpropanoyl)guanosine

Conditions
ConditionsYield
In pyridine at 110℃; for 20h;98%
With dmap In pyridine at 50℃; for 24h;
5,6-dimethyl-1H-benzo[d]imida-zole
582-60-5

5,6-dimethyl-1H-benzo[d]imida-zole

(β-D-ribofuranosyl)-5,6-dimethylbenzimidazole
13082-84-3

(β-D-ribofuranosyl)-5,6-dimethylbenzimidazole

Conditions
ConditionsYield
for 1.5h; purine nucleoside phosphorylase of whole cells of E. coli BMT 1D/1A;98%
Phenoxyacetyl chloride
701-99-5

Phenoxyacetyl chloride

N2-(phenoxyacetyl)guanosine
119824-66-7

N2-(phenoxyacetyl)guanosine

Conditions
ConditionsYield
Stage #1: G With pyridine; chloro-trimethyl-silane In dichloromethane for 2h;
Stage #2: Phenoxyacetyl chloride In dichloromethane at 0℃; for 3h;
Stage #3: With methanol In dichloromethane at 20℃; for 12h;
98%
With pyridine; chloro-trimethyl-silane; benzotriazol-1-ol 1.) 45 min, 2.) acetonitrile, 55 deg C, 5 h; Yield given. Multistep reaction;
Stage #1: G With pyridine; chloro-trimethyl-silane In dichloromethane at 0 - 20℃; for 3h; Inert atmosphere;
Stage #2: Phenoxyacetyl chloride In dichloromethane for 3h; Cooling with ice;
150.2 g
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

Conditions
ConditionsYield
With sulfuric acid In water at 90℃; for 1.5h; Reagent/catalyst; Temperature; Solvent; Large scale;98%
With sodium dichromate In water at 24.85℃; Quantum yield; Further Variations:; Reagents; pH-values; Decomposition; Photolysis;
With Lupinus luteus guanosine-inosine nucleosidase Enzyme kinetics;
acetone
67-64-1

acetone

2',3'-isopropylideneguanosine
362-76-5

2',3'-isopropylideneguanosine

Conditions
ConditionsYield
With perchloric acid at 20℃; for 1.16667h;98%
With perchloric acid In water at 20℃; for 4h;94%
Stage #1: G; acetone With perchloric acid at 20℃; for 1.16667h;
Stage #2: With ammonia In water at 0℃;
92%
acetyl chloride
75-36-5

acetyl chloride

N2-acetylguanosine
129681-72-7, 21967-06-6

N2-acetylguanosine

Conditions
ConditionsYield
Stage #1: G With pyridine; chloro-trimethyl-silane In dichloromethane for 2h;
Stage #2: acetyl chloride In dichloromethane at 0℃; for 1.5h;
Stage #3: With methanol In dichloromethane at 20℃; for 12h;
98%
(diethylenetriamino)copper(II) nitrate

(diethylenetriamino)copper(II) nitrate

sodium nicotinate
54-86-4

sodium nicotinate

water
7732-18-5

water

[Cu(diethylenetriamine)(nicotinic acid-H)(N7-guanosine)(NO3)]*5H2O

[Cu(diethylenetriamine)(nicotinic acid-H)(N7-guanosine)(NO3)]*5H2O

Conditions
ConditionsYield
In methanol; ethanol; water soln. of sodium nicotinate (5 mmol) in H2O/EtOH (1/10 v/v) added dropwise to soln. of Cu complex (5 mmol) in H2O/MeOH (1/10 v/v); stirred (5 min); guanosine (5 mmol) in EtOH added; stirred (12 h); solid isolated by filtration; washed with Et2O; dried (room temp.); elem. anal.;98%
ethyl iodide
75-03-6

ethyl iodide

7-ethylguanine hydrochloride

7-ethylguanine hydrochloride

Conditions
ConditionsYield
Stage #1: ethyl iodide; G In N,N-dimethyl acetamide at 20℃; for 24h;
Stage #2: With hydrogenchloride for 1.5h; Heating;
97%
propionic acid anhydride
123-62-6

propionic acid anhydride

2',3',5'-tri-O-propionyl-N2-propionylguanosine
90742-12-4

2',3',5'-tri-O-propionyl-N2-propionylguanosine

Conditions
ConditionsYield
With dmap In pyridine at 70℃; for 3h;96%
dimethyl sulfate
77-78-1

dimethyl sulfate

7-methylguanine hydrochloride

7-methylguanine hydrochloride

Conditions
ConditionsYield
Stage #1: G; dimethyl sulfate In N,N-dimethyl acetamide at 20℃; for 6h;
Stage #2: With hydrogenchloride for 1.5h; Heating;
96%
acetic anhydride
108-24-7

acetic anhydride

A

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

B

1,2,3,5-tetraacetylribose
13035-61-5

1,2,3,5-tetraacetylribose

Conditions
ConditionsYield
Stage #1: acetic anhydride; G at 136℃; for 1h;
Stage #2: With trifluoroacetic acid at 60 - 100℃;
A 96%
B 86%
acetic anhydride
108-24-7

acetic anhydride

2-amino-6-hydroxyl-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine
6979-94-8

2-amino-6-hydroxyl-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine

Conditions
ConditionsYield
With dmap; triethylamine In acetonitrile at 20℃; for 0.5h;96%
With dmap; triethylamine In acetonitrile at 20℃; for 0.666667h;96%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

5'-O-tert-butyldimethylsilylguanosine
72409-21-3

5'-O-tert-butyldimethylsilylguanosine

Conditions
ConditionsYield
With silver nitrate In tetrahydrofuran for 3h; Ambient temperature;95%
silver nitrate In tetrahydrofuran for 1h;95%
With dmap; triethylamine In dichloromethane; dimethyl sulfoxide at 20℃; for 24h; Inert atmosphere;87%
1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane
69304-37-6

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane

3',5'-O-1,1,3,3-tetraisopropyldisiloxan-1,3-diyl-guanosine
69304-44-5

3',5'-O-1,1,3,3-tetraisopropyldisiloxan-1,3-diyl-guanosine

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide for 0.75h; Ambient temperature;95%
With 1H-imidazole In pyridine; N,N-dimethyl-formamide for 4h;93%
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere; Large scale;92%
di-tert-butylsilyl bis(trifluoromethanesulfonate)
85272-31-7

di-tert-butylsilyl bis(trifluoromethanesulfonate)

2-amino-9-((4aR,6R,7R,7aS)-2,2-di-tert-butyl-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl)-1,9-dihydro-6H-purin-6-one
126628-29-3

2-amino-9-((4aR,6R,7R,7aS)-2,2-di-tert-butyl-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl)-1,9-dihydro-6H-purin-6-one

Conditions
ConditionsYield
In N,N-dimethyl-formamide95%
With 2,6-dimethylpyridine In N,N-dimethyl-formamide at 0 - 20℃; for 1h; Inert atmosphere;95%
In N,N-dimethyl-formamide at 0℃; Inert atmosphere;89%
N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

N2-[(dimethylamino)methylene]guanosine
1055407-32-3

N2-[(dimethylamino)methylene]guanosine

Conditions
ConditionsYield
In methanol at 27℃; for 96h;95%
oxirane
75-21-8

oxirane

7-(2'-hydroxyethyl)guanine hydrochloride

7-(2'-hydroxyethyl)guanine hydrochloride

Conditions
ConditionsYield
Stage #1: oxirane; G With acetic acid at 100℃; for 0.5h;
Stage #2: With hydrogenchloride for 1.5h; Heating;
95%
palladium diacetate
3375-31-3

palladium diacetate

Pd(2+)*CH3COO(1-)*C10H12N5O5(1-)*3H2O=[Pd(CH3COO)(C10H12N5O5)]*3H2O

Pd(2+)*CH3COO(1-)*C10H12N5O5(1-)*3H2O=[Pd(CH3COO)(C10H12N5O5)]*3H2O

Conditions
ConditionsYield
In water; acetone stirring (hot soln., 3 h), pptn.; centrifugation, washing (water, acetone), drying (air); elem. anal.;95%
ethyl iodide
75-03-6

ethyl iodide

7-ethylguanine

7-ethylguanine

Conditions
ConditionsYield
Stage #1: ethyl iodide; G In N,N-dimethyl acetamide at 60℃; Inert atmosphere;
Stage #2: With hydrogenchloride In N,N-dimethyl acetamide; water at 110℃; for 1h;
Stage #3: With ammonia In N,N-dimethyl acetamide; water at 20℃;
95%
Stage #1: ethyl iodide; G In N,N-dimethyl acetamide at 60℃; Inert atmosphere;
Stage #2: With hydrogenchloride In N,N-dimethyl acetamide; water at 110℃; for 1h;
95%

118-00-3Related news

Guanosine (cas 118-00-3) protects against Ca2+-induced mitochondrial dysfunction in rats09/03/2019

Mitochondria play an important role in cell life and in the regulation of cell death. In addition, mitochondrial dysfunction contributes to a wide range of neuropathologies. The nucleoside Guanosine (GUO) is an endogenous molecule, presenting antioxidant properties, possibly due to its direct sc...detailed

Elevated plasma cyclic Guanosine (cas 118-00-3) monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report☆09/02/2019

Cyclic guanosine monophosphate (cGMP) influences intrarenal hemodynamics in animal models, but the relationship between cGMP and renal function in adults with type 1 diabetes (T1D) remains unclear. In this study, plasma cGMP correlated with efferent arteriolar resistance, effective renal plasma ...detailed

Guanosine (cas 118-00-3) exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling08/30/2019

BackgroundGuanosine is a natural product and an endogenous nucleoside that has shown to increase during myocardial ischemia. Platelets are critically involved in ischemic coronary events. It remains unknown, however, whether guanosine may affect platelet activation and function. We sought to inv...detailed

Augmentation effect of ketamine by Guanosine (cas 118-00-3) in the novelty-suppressed feeding test is dependent on mTOR signaling pathway08/26/2019

The ketamine's potential for the treatment of refractory depression and anxiety has been considered one the most important discoveries in the last years, however, repeated use of ketamine is limited due to its side/adverse effects. Therefore, the search for effective augmentation strategies...detailed

118-00-3Relevant articles and documents

Simple method for fast deprotection of nucleosides by triethylamine- catalyzed methanolysis of acetates in aqueous medium

Meier, Lidiane,Monteiro, Gustavo C.,Baldissera, Rodrigo A.M.,Sa?, Marcus Mandolesi

, p. 859 - 866 (2010)

A straightforward methodology for deacetylation of protected ribonucleosides was developed based on triethylamine-catalyzed solvolysis in aqueous methanol. Reactions are completed in a few minutes under microwave irradiation and the free nucleosides are obtained in high yield after simple evaporation of volatiles. Other important features include the involvement of readily available reagents and the compatibility with diverse functional groups, which make this process very attractive for broad application.

Heterocyclic Synthesis via a 1,3-Dicyclohexylcarbodiimide-Mediated Cyclodesulfurative Annulation Reaction. New Methodology for the Preparation of Guanosine and Guanosine-Type Nucleoside Analogues

Groziak, Michael P.,Chern, Ji-Wang,Townsend, Leroy B.

, p. 1065 - 1069 (1986)

Treatment of 5-amino-1-β-D-ribofuranosylimidazole-4-carboxamide (1, AICA-ribonucleoside) with methoxycarbonyl isothiocyanate followed by cyclodesulfurization of the resulting methoxycarbonylated thioureido derivative with 1,3-dicyclohexylcarbodiimide (DCC) has furnished 5--1-β-D-ribofuranosylimidazole-4-carbonitrile (6), not 2--9-β-D-ribofuranosylpurin-6-one (4).Using 1 labeled with 18O in the carboxamide moiety, the conversion of 1 to 6 is shown to proceed with retention of the 18O label.This finding has suggested the presence of a oxazine intermediate in an intramolecular dehydration reaction mechanism.Under similar reaction conditions, methyl 5-amino-1-β-D-ribofuranosylimidazole-4-carboximidate (13) affords 6-methoxy-2--9-β-D-ribofuranosylpurine (14), which gives guanosine upon deprotection with iodotrimethylsilane.The use of this methoxycarbonyl isothiocyanate/DCC cyclodesulfurization method on heterocyclic o-amino carboximidate esters thus provides a highly efficient entry into the class of guanosine-type nucleoside analogues.

N,N-Dibenzyl formamidine as a new protective group for primary amines

Vincent, Stephane,Mons, Stephane,Lebeau, Luc,Mioskowski, Charles

, p. 7527 - 7530 (1997)

Primary amines can be converted in high yield into N,N-dibenzyl formamidines under mild conditions. The N,N-dibenzyl formamidine group was found to be effective as a protective group for primary amines as it is stable to a variety of conditions and can be removed by catalytic hydrogenation.

Phosphorylating reagent-free synthesis of 5′-phosphate oligonucleotides by controlled oxidative degradation of their 5′-end

Sallamand, Corinne,Miscioscia, Audrey,Lartia, Remy,Defrancq, Eric

, p. 2030 - 2033 (2012)

The 5′-phosphorylated oligonucleotides (5′-pONs) are currently synthesized using expensive and sensitive modified phosphoramidite reagents. In this work, a simple, cost-effective, efficient, and automatable method is presented, based on the controlled oxidation of the 5′-terminal alcohol followed by a β-elimination reaction. The latter reaction leads to the removal of the terminal 5′-nucleoside and subsequent formation of the 5′-phosphate moiety. Thus, chemical phosphorylation of oligonucleotides (DNA or RNA) is achieved without using modified phosphoramidites.

THE PROTECTION OF 2'-HYDROXY FUNCTIONS IN OLIGORIBONUCLEOTIDE SYNTHESIS

Norman, G. David,Reese, B. Colin,Serafinowska, T. Halina

, p. 3015 - 3018 (1984)

The suitability of the 4-methoxytetrahydropyran-4-yl group for the protection of 2' ( or 3')-hydroxy functions in oligoribonucleotide synthesis is confirmed; the latter protecting group is removed in 0.01M-hydrochloric acid at room temperature under conditions which, contrary to a recent report, lead to no detectable cleavage or migration of the internucleotide phosphodiester linkages.

Chemical radiation studies of 8-bromoguanosine in aqueous solutions

Ioele, Marcella,Bazzanini, Rita,Chatgilialoglu, Chryssostomos,Mulazzani, Quinto G.

, p. 1900 - 1907 (2000)

Chemical radiolytic methods were used to investigate the reactions of hydrated electrons (eaq-) with 8-bromoguanosine (8-Br-Guo) as a function of pH. γ-Radiolysis of 8-Br-Guo in aqueous solutions followed by product studies showed the formation of guanosine (Guo) as a single product at various pH. In D2O solutions the quantitative incorporation of deuterium at the 8-position was also observed. Pulse radiolysis revealed the instantaneous formation of a guanosine radical cation (Guo.+ or its deprotonated forms) in acid or basic solutions. The same transient species results from the reaction of H. with 8-Br-Guo at pH 3, as well as from the reaction of (CH3)2CO.- with 8-Br-Guo at pH 13. In neutral solution, the initial electron adduct was rapidly protonated to give the first observable transient species that decays by first-order kinetics (k = 5 × 104 s-1) to produce the Guo(-H+). radical once again. Tailored experiments allowed the reaction mechanism to be defined in some detail.

Hydrolytic reactions of guanosyl-(3′,3′)-uridine and guanosyl-(3′,3′)-(2′,5′-di-O-methyluridine)

Kiviniemi, Anu,Loennberg, Tuomas,Ora, Mikko

, p. 11040 - 11045 (2004)

Hydrolytic reactions of guanosyl-(3′,3′)-uridine and guanosyl-(3′,3′)-(2′,5′-di-O-methyluridine) have been followed by RP HPLC over a wide pH range at 363.2 K in order to elucidate the role of the 2′-hydroxyl group as a hydrogen-bond donor upon departure of the 3′-uridine moiety. Under neutral and basic conditions, guanosyl-(3′,3′)-uridine undergoes hydroxide ion-catalyzed cleavage (first order in [OH-]) of the P-O3′ bonds, giving uridine and guanosine 2′,3′-cyclic monophosphates, which are subsequently hydrolyzed to a mixture of 2′- and 3′-monophosphates. This bond rupture is 23 times as fast as the corresponding cleavage of the P-O3′ bond of guanosyl-(3′,3′)-(2,5′-di-O-methyluridine) to yield 2′,5′-O-dimethyluridine and guanosine 2′,3′-cyclic phosphate. Under acidic conditions, where the reactivity differences are smaller, depurination and isomerization compete with the cleavage. The effect of Zn2+ on the cleavage of the P-O3′ bonds of guanosyl-(3′,3′)-uridine is modest: about 6-fold acceleration was observed at [Zn2+] = 5 mmol L-1 and pH 5.6. With guanosyl-(3′,3′)-(2′,5′-di-O-methyluridine) the rate-acceleration effect is greater: a 37-fold acceleration was observed. The mechanisms of the partial reactions, in particular the effects of the 2′-hydroxyl group on the departure of the 3′-linked nucleoside, are discussed.

A kinetic study of the rat liver adenosine kinase reverse reaction

Vannoni,Giglioni,Santoro,Aceto,Marinello,Leoncini

, p. 872 - 875 (2008)

Adenosine kinase is an enzyme catalyzing the reaction: adenosine + ATP → AMP + ADP. We studied some biochemical properties not hitherto investigated and demonstrated that the reaction can be easily reversed when coupled with adenosine deaminase, which transforms adenosine into inosine and ammonia. The overall reaction is: AMP + ADP → ATP + inosine + NH3. The exoergonic ADA reaction shifts the equilibrium and fills the energy gap necessary for synthesis of ATP. This reaction could be used by cells under particular conditions of energy deficiency and, together with myokinase activity, may help to restore physiological ATP levels. Copyright Taylor & Francis Group, LLC.

Kiteplatin: Differential binding between GSH and GMP

Petruzzella, Emanuele,Curci, Alessandra,Margiotta, Nicola,Natile, Giovanni,Hoeschele, James D.

, p. 130 - 136 (2016)

Glutathione (GSH) plays an important role in the development of resistance to platinum-based chemotherapy, since it can prevent drug binding to DNA and resulting apoptosis of tumor cells. The recently re-discovered drug candidate kiteplatin was found active toward cisplatin- and oxaliplatin-resistant tumor cells, and this could be related to a different interplay of drug-inactivation/DNA-interaction processes. In this study GSH and GMP have been chosen as simple models of platinophiles and DNA, respectively, and the reactivity of kiteplatin has been tested toward GMP, after previous interaction with GSH; toward GSH, after previous interaction with GMP; and toward GMP and GSH simultaneously.

1,1,1,3,3,3-Hexafluoro-2-propanol for the Removal of the 4,4'-Dimethoxytrityl Protecting Group from the 5'-Hydroxyl of Acid-Sensitive Nucleosides and Nucleotides

Leonard, Nelson J.,Neelima

, p. 7833 - 7836 (1995)

1,1,1,3,3,3-Hexafluoro-2-propanol is introduced as a suitable reagent and solvent for the detritylation of 5'-O-(4,4'-dimethoxytrityl)-nucleosides and -deoxy- nucleosides, especially those that are susceptible to N-glycosyl cleavage under more strongly acidic conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 118-00-3